Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:02 2024-04-23 pm EDT 5-day change 1st Jan Change
10.84 USD -2.34% Intraday chart for Treace Medical Concepts, Inc. -5.98% -14.98%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction MT
Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M MT
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024 CI
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes MT
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions CI
Transcript : Treace Medical Concepts, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:45 PM
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $16 From $12, Keeps Buy Rating MT
UBS Adjusts Price Target on Treace Medical Concepts to $17 From $24, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $14 From $30, Maintains Overweight Rating MT
Truist Adjusts Price Target on Treace Medical Concepts to $12 From $17, Maintains Buy Rating MT
Sector Update: Health Care Stocks Advance Premarket Friday MT
Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook MT
Transcript : Treace Medical Concepts, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Posts Q3 Revenue $40.8M, vs. Street Est of $42.1M MT
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023 CI
UBS Initiates Treace Medical Concepts With Buy Rating, Price Target is $24 MT
Treace Medical Concepts, Inc. Highlights New Product Innovations and Updated Align3d Clinical Study Data At the American Orthopaedic Foot & Ankle Society Annual Meeting 2023 CI
Transcript : Treace Medical Concepts, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 08:10 AM
Treace Medical Concepts, Inc. Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures CI
North American Morning Briefing : Investors Look -2- DJ
Chart Treace Medical Concepts, Inc.
More charts
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
11.1 USD
Average target price
15.86 USD
Spread / Average Target
+42.86%
Consensus
  1. Stock Market
  2. Equities
  3. TMCI Stock
  4. News Treace Medical Concepts, Inc.
  5. Treace Medical Concepts Receives Patent, Allowance of Patent Application on Bone Positioner Technology for Bunion Correction